The Boehringer Ingelheim Venture Fund invests in pioneering science that aims to redefine the standard of care and bring new medicines to patients. They focus on acquiring minority stakes in biotech start-ups and support their funding and growth.
Deal activity and portfolio updates would appear here
Connect your data source to see recent transactions